Sivia Capital Partners LLC Takes $228,000 Position in Colgate-Palmolive (NYSE:CL)

Sivia Capital Partners LLC bought a new position in Colgate-Palmolive (NYSE:CLFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,507 shares of the company’s stock, valued at approximately $228,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new position in Colgate-Palmolive in the third quarter valued at about $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive in the 3rd quarter worth about $64,000. True Wealth Design LLC lifted its holdings in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after buying an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC grew its stake in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have issued reports on CL. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $103.63.

Read Our Latest Research Report on CL

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $0.61 during midday trading on Monday, reaching $86.97. The company had a trading volume of 5,275,657 shares, compared to its average volume of 4,862,452. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The company has a market capitalization of $71.06 billion, a price-to-earnings ratio of 24.92, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The stock has a fifty day simple moving average of $92.62 and a 200 day simple moving average of $98.06.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.